Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept

Transplantation. 2021 Sep 1;105(9):e94-e95. doi: 10.1097/TP.0000000000003784.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abatacept / therapeutic use
  • Immunosuppressive Agents / adverse effects
  • Kidney Transplantation* / adverse effects
  • RNA, Messenger
  • SARS-CoV-2
  • T-Lymphocytes
  • Transplant Recipients
  • Vaccines*

Substances

  • Immunosuppressive Agents
  • RNA, Messenger
  • Vaccines
  • Abatacept